Genetic modifiers of sickle cell disease

Cited by (316)

Items 101–200 of 316

1. A candidate transacting modulator of fetal hemoglobin gene expression in the Arab-Indian haplotype of sickle cell anemia
   Vathipadiekal, Vinod, Farrell, John J., Wang, Shuai, Edward, Heather L., Shappell, Heather, Al‐Rubaish, A.M., Al‐Muhanna, Fahad, Naserullah, Z., Alsuliman, A., Qutub, Hatem Othman et al. · 2016 · American Journal of Hematology
2. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
   Pierre Allard, Nareen Alhaj, Stephan Lobitz, Holger Cario, Andrea Jarisch, Regine Grosse, Lena Oevermann, Dani Hakimeh, Laura Tagliaferri, ELISABETH KOHNE et al. · 2021 · Haematologica
3. Red Cell Alloimmunization and Autoimmunization Among Sickle Cell Disease and Thalassemia Patients in Jazan Province, Saudi Arabia
   Amr J Halawani, Abdullah A Mobarki, Ali H Arjan, Muhammad Saboor, Hassan Abdu Hamali, Gasim Dobie, Khalaf F Alsharif · 2022 · International Journal of General Medicine
4. Coinheritance of sickle cell anemia and α‐thalassemia delays disease onset and could improve survival in cameroonian's patients (Sub‐Saharan Africa)
   Ambroise Wonkam, Maryam Bibi Rumaney, Valentina Josiane Ngo Bitoungui, Anna Alvera Vorster, Raj Ramesar, Jeanne Yonkeu Ngogang · 2014 · American Journal of Hematology
5. Perception of Pain Among Pediatric Patients With Sickle Cell Pain Crisis
   Marian B. Fosdal · 2014 · Journal of Pediatric Oncology Nursing
6. Cognitive and fine motor deficits in a pediatric sickle cell disease cohort of mixed ethnic origin
   Luise Burkhardt, Stephan Lobitz, Elisabeth Koustenis, Stefan Mark Rueckriegel, Pablo Hernáiz Driever · 2016 · Annals of Hematology
7. Angiopoietin-2 as a Marker of Retinopathy in Children and Adolescents With Sickle Cell Disease: Relation to Subclinical Atherosclerosis
   Nevine Gamal Andrawes, Eman Abdel Rahman Ismail, Maged Maher Salib Roshdy, Fatma Soliman Elsayed Ebeid, Deena Samir Eissa, Amna Ibrahim · 2019 · Journal of Pediatric Hematology/Oncology
8. Defining curative endpoints for transfusion‐dependent β‐thalassemia in the era of gene therapy and gene editing
   Selim Corbacioglu, Haydar Frangoul, Franco Locatelli, William Hobbs, Mark C. Walters · 2023 · American Journal of Hematology
9. Haptoglobin gene polymorphisms and interleukin-6 and -8 levels in patients with sickle cell anemia
   Bruna Spinella Pierrot-Gallo, Perla Vicari, Sandra Satiko Matsuda, Samuel Ademola Adegoke, Grazielle Mecabô, Maria Stella Figueiredo · 2015 · Revista Brasileira de Hematologia e Hemoterapia
10. The genetic dissection of fetal haemoglobin persistence in sickle cell disease in Nigeria
    Oyesola Oyewole Ojewunmi, Titilope Adenike Adeyemo, Ajoke Idayat Oyetunji, Bassey A. Inyang, Afolashade Akinrindoye, Baraka Stewart Mkumbe, Kate Gardner, Helen Rooks, John N. Brewin, Hamel Patel et al. · 2024 · Human Molecular Genetics
11. Minireview: Multiomic candidate biomarkers for clinical manifestations of sickle cell severity: Early steps to precision medicine
    Steven R. Goodman, Betty S. Pace, Kirk Charles Hansen, Angelo D’Alessandro, Yang Xia, Ovidiu Daescu, Stephen J. Glatt · 2016 · Experimental Biology and Medicine
12. The association between four SNPs (rs7482144, rs4671393, rs28384513 and rs4895441) and fetal hemoglobin levels in Chinese Zhuang β-thalassemia intermedia patients
    Yunli Lai, Lin Zhou, Sheng Yi, Yun Chen, Yanqing Tang, Shang Yi, Ze Yang, Hongwei Wei, Chenguang Zheng, sheng tao he · 2017 · Blood Cells Molecules and Diseases
13. Genetic Modifiers at the Crossroads of Personalised Medicine for Haemoglobinopathies
    Coralea Stephanou, Stella Tamana, Anna Minaidou, Panayiota L. Papasavva, Marina Kleanthous, Petros Kountouris · 2019 · Journal of Clinical Medicine
14. Interventions for preventing silent cerebral infarcts in people with sickle cell disease
    Lise J Estcourt, Catherine Kimber, Sally Hopewell, Marialena Trivella, Carolyn J. Doree, Miguel Raul Abboud · 2020 · Cochrane Database of Systematic Reviews
15. Genomic architecture of sickle cell disease in West African children
    Jacklyn Quinlan, Youssef Idaghdour, Jean-Philippe Goulet, Elias Gbeha, Thibault de Malliard, Vanessa Bruat, Jean‐Christophe Grenier, Selma Gomez, Ambaliou Sanni, Mohamed Chérif Rahimy et al. · 2014 · Frontiers in Genetics
16. Plasma levels of TGF-β1 in homeostasis of the inflammation in sickle cell disease
    Lidiane S. Torres, Jéssika Viviani Okumura, Danilo Grünig Humberto da Silva, Edis Belini-Junior, Renan Garcia de Oliveira, Kallyne Kioko Oliveira Mimura, Clarisse Lopes de Castro Lobo, Sônia Maria Oliani, Cláudia R. Bonini-Domingos · 2016 · Cytokine
17. Association between sickle cell anemia and alpha thalassemia reveals a high prevalence of the α3.7 triplication in congolese patients than in worldwide series
    Tite Minga Mikobi, Prosper Lukusa-Tshilobo, Michel Ntetani Aloni, Aimé Zola Lumaka, Pierre Zalagile Akilimali, Koenraad Devriendt, Gert Matthijs, Jean‐Marie Mbuyi Muamba, Valérie Race · 2017 · Journal of Clinical Laboratory Analysis
18. Targeting fetal hemoglobin expression to treat β hemoglobinopathies
    Martin H. Steinberg · 2022 · Expert Opinion on Therapeutic Targets
19. Prevalence of pain-related single nucleotide polymorphisms in patients of African origin with sickle cell disease
    Ellie H. Jhun, Yingwei Yao, Ying He, Mack A. Kyle, Diana J. Wilkie, R. Molokie, Z. Wang · 2015 · Pharmacogenomics (London)
20. Sickle Cell Disease: A Genetic Disorder of Beta-Globin
    Karen Cordovil · 2018 · InTech eBooks
21. In utero Therapy for the Treatment of Sickle Cell Disease: Taking Advantage of the Fetal Immune System
    Alba Sáenz de Villaverde Cortabarría, Laura Makhoul, John Strouboulis, Giovanna Lombardi, Eugene Oteng‐Ntim, Panicos Shangaris · 2021 · Frontiers in Cell and Developmental Biology
22. Priapism in sickle cell disease: Associations between NOS3 and EDN1 genetic polymorphisms and laboratory biomarkers
    Camylla Vilas Boas Figueiredo, Rayra Pereira Santiago, Caroline Conceição da Guarda, Rodrigo Mota de Oliveira, Luciana Magalhães Fiuza, Sètondji Cocou Modeste Alexandre Yahouédéhou, Suéllen Pinheiro Carvalho, Joelma Santana dos Santos Neres, Antonio Mateus de Jesus Oliveira, Cleverson Alves Fonseca et al. · 2021 · PLoS ONE
23. Global analysis of suppressor mutations that rescue human genetic defects
    Betül Ünlü, Carles Pons, Uyen Linh Ho, Amandine Batté, Patrick Aloy, Jolanda S. van Leeuwen · 2023 · Genome Medicine
24. Genetic variation in CD 36, HBA , NOS 3 and VCAM 1 is associated with chronic haemolysis level in sickle cell anaemia: a longitudinal study
    Andreia Coelho, Alexandra Dias, Anabela Morais, Baltazar Nunes, Emanuel Ferreira, Isabel Picanço, Paula Faustino, João Lavinha · 2013 · European Journal Of Haematology
25. Evaluation of oxidative stress-related genetic variants for predicting stroke in patients with sickle cell anemia
    Igor F. Domingos, Diego A. Pereira‐Martins, Rayssa Leal Borges-Medeiros, Diego Arruda Falcão, Betânia Lucena Domingues Hatzlhofer, John N. Brewin, Kate Gardner, Taciana Furtado de Mendonça Belmont, M.S.M. Cavalcanti, Anderson Ferreira da Cunha et al. · 2020 · Journal of the Neurological Sciences
26. Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing
    Adekunle D. Adekile, Nagihan Akbulut-Jeradi, Rasha Al Khaldi, Maria Fernandez, Jalaja Sukumaran · 2021 · Journal of Personalized Medicine
27. Development of pathophysiologically relevant models of sickle cell disease and β-thalassemia for therapeutic studies
    Pragya Gupta, Sangam Giri Goswami, Geeta Kumari, Vinodh Saravanakumar, Nupur Bhargava, Akhila Balakrishna Rai, Praveen Singh, Rahul C. Bhoyar, Arvinden VR, Padma Gunda et al. · 2024 · Nature Communications
28. Influence of alpha thalassemia on clinical and laboratory parameters among nigerian children with sickle cell anemia
    Oladele Simeon Olatunya, Dulcinéia Martins de Albuquerque, Adekunle D. Adekile, Fernando Ferreira Costa · 2018 · Journal of Clinical Laboratory Analysis
29. Haemoglobin disorders in Australia: where are we now and where will we be in the future?
    Gemma Louise Crighton, Erica M. Wood, Ri Scarborough, Phoebe Joy Ho, D. K. Bowden · 2016 · Internal Medicine Journal
30. Genetic modulation of fetal hemoglobin in hydroxyurea‐treated sickle cell anemia
    Milena Magalhães Aleluia, Rayra Pereira Santiago, Caroline Conceição da Guarda, Teresa Cristina Cardoso Fonseca, Fábia Idalina Neves, Regiana Quinto de Souza, Camylla V. B. Figueiredo, Sètondji Cocou Modeste Alexandre Yahouédéhou, Rodrigo Mota de Oliveira, Júnia Raquel Dutra Ferreira et al. · 2017 · American Journal of Hematology
31. Transcranial Doppler Ultrasound in Peninsular Arab Patients With Sickle Cell Disease
    Adekunle D. Adekile, Meàad Kadhum Hassan, Akram Mahmoud Asbeutah, Mohamed Al‐Hinai, Omar Trad, Nayef Farhan · 2018 · Journal of Ultrasound in Medicine
32. Genetic comparison of sickle cell anaemia cohorts from Brazil and the United States reveals high levels of divergence
    Pedro Rodrigues Sousa da Cruz, Galina Ananina, Vera Lúcia Gil‐da‐Silva‐Lopes, Milena Simioni, Farid Menaa, Marcos André Cavalcanti Bezerra, Igor F. Domingos, Aderson Silva Araujo, Renata Pellegrino, Hakon H. Hakonarson et al. · 2019 · Scientific Reports
33. Haptoglobin Gene Polymorphism in Patients with Sickle Cell Anemia: Findings from a Nigerian Cohort Study
    Oladele Simeon Olatunya, Dulcinéia Martins de Albuquerque, Magnun Nueldo Nunes Santos, Tolorunju Segun Kayode, Adekunle D. Adekile, Fernando Ferreira Costa · 2020 · The Application of Clinical Genetics
34. Loss of alpha‐globin genes in human subjects is associated with improved nitric oxide‐mediated vascular perfusion
    Christopher Clement Denton, Payal Shah, Silvie Suriany, Honglei Liu, Wanwara Thuptimdang, John Sunwoo, Patjanaporn Chalacheva, Saranya Veluswamy, Roberta Miyeko Kato, John C. Wood et al. · 2020 · American Journal of Hematology
35. <b><i>ANTXR1</i></b> Intronic Variants Are Associated with Fetal Hemoglobin in the Arab-Indian Haplotype of Sickle Cell Disease
    Al-Ali, Zhara A., Fallatah, Rana K., Aljaffer, Esra A., Albukhari, Eman R., Sadek Al-Ali, Neriman, Al-Ghannam, Ziyad T., Sayeb Al-Atrash, Reem, Alsuliman, Ahmed, Vatte, Chittibabu · 2018 · Acta Haematologica
36. Sickle Cell Disease
    Joachim B. Kunz, Laura Tagliaferri · 2024 · Transfusion Medicine and Hemotherapy
37. Utilizing Whole-Exome Sequencing to Characterize the Phenotypic Variability of Sickle Cell Disease
    Abdulrahman S. Alsultan, Ahmed M. AlSuliman, Aamer Aleem, Farjah H AlGahtani, Majid Alfadhel · 2018 · Genetic Testing and Molecular Biomarkers
38. Stakeholder Perspectives on Public Health Genomics Applications for Sickle Cell Disease: A Methodology for a Human Heredity and Health in Africa (H3Africa) Qualitative Research Study
    Marsha J. Treadwell, Julie Makani, Kwaku Ohene‐Frempong, Solomon Fiifi Ofori-Acquah, Sheryl McCurdy, Jantina de Vries, Daima Bukini, Jemima Dennis-Antwi, Karen Kengne Kamga, Columba Kokusiima Mbekenga et al. · 2017 · OMICS A Journal of Integrative Biology
39. The association of HBG2 , BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease
    Nasir A.S. Al-Allawi, Shatha M. A. Qadir, Helene Puehringer, David H.K. Chui, John J. Farrell, Christian Oberkanins · 2018 · International Journal of Laboratory Hematology
40. Angiotensinogen M235T Gene Polymorphism is a Genetic Determinant of Cerebrovascular and Cardiopulmonary Morbidity in Adolescents with Sickle Cell Disease
    Mohsen Saleh Elalfy, Fatma Soliman Elsayed Ebeid, Tarek M. Kamal, Deena Samir Eissa, Eman Abdel Rahman Ismail, Samar Hassan Mohamed · 2018 · Journal of Stroke and Cerebrovascular Diseases
41. Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing
    Franco Locatelli, Selim Corbacioglu, William Hobbs, Haydar Frangoul, Mark C. Walters · 2023 · American Journal of Hematology
42. The different facets of sickle cell disease-related pulmonary hypertension
    Clare C. Prohaska, Roberto F. Machado · 2021 · Current Opinion in Pulmonary Medicine
43. Clinical Factors Associated With Morbidity and Mortality in Patients Admitted with Sickle Cell Disease
    Karen Galloway-Blake, Marvin Ellsworth Reid, C Walters, Jacqueline Jaggon, MG Lee · 2015 · West Indian Medical Journal
44. Variants in the non-coding region of the TLR2 gene associated with infectious subphenotypes in pediatric sickle cell anemia
    Susana David, Pedro Manuel Vargues Aguiar, Liliana Antunes, Alexandra Dias, Anabela Morais, Anavaj Sakuntabhai, João Lavinha · 2017 · Immunogenetics
45. TNFSF/TNFRSF cytokine gene expression in sickle cell anemia: Up-regulated TNF-like cytokine 1A (TL1A) and its decoy receptor (DcR3) in peripheral blood mononuclear cells and plasma
    Surinder Safaya, Mohammed Farhan A. Alfarhan, Ahmed Sulaiman, Abdulla A. Alsulaiman, Amein K. Al‐Ali · 2019 · Cytokine
46. Sideroblastic anemia: functional study of two novel missense mutations in ALAS 2
    Manuel Méndez, María‐Isabel Moreno‐Carralero, Marta Morado‐Arias, Maria-Cristina Fernández-Jiménez, Silvia de la Iglesia, María‐Josefa Morán‐Jiménez · 2016 · Molecular Genetics & Genomic Medicine
47. Interventions for chronic kidney disease in people with sickle cell disease
    Noemi B. A. Roy, Patricia M Fortin, Katherine R. Bull, Carolyn J. Doree, Marialena Trivella, Sally Hopewell, Lise J Estcourt · 2016 · Cochrane Database of Systematic Reviews
48. Genotypic Diversity among Angolan Children with Sickle Cell Anemia
    Mariana Delgadinho, Catarina Ginete, Brígida Santos, Armandina Miranda, Miguel Brito · 2021 · International Journal of Environmental Research and Public Health
49. Crosstalk Between Sickle Cell Disease and Ferroptosis
    Annamaria Russo, Giuseppe Tancredi Patanè, Antonella Calderaro, Davide Barreca, Ester Tellone, Stefano Putaggio · 2025 · International Journal of Molecular Sciences
50. Decoding ‘Unnecessary Complexity’: A Law of Complexity and a Concept of Hidden Variation Behind “Missing Heritability” in Precision Medicine
    Rama Shankar Singh · 2021 · Journal of Molecular Evolution
51. Whole blood transcriptomic analysis reveals PLSCR4 as a potential marker for vaso-occlusive crises in sickle cell disease
    Hawra Abdulwahab, Muna Aljishi, Ameera Sultan, Ghada Al‐Kafaji, Kannan Sridharan, Moiz Bakhiet, Safa Taha · 2021 · Scientific Reports
52. Genetic Factors Modifying Sickle Cell Disease Severity
    Kate Gardner, Swee Lay Thein · 2016 · Springer eBooks
53. Heritability of fetal hemoglobin, white cell count, and other clinical traits from a sickle cell disease family cohort
    Erik L. Bao, Caleb A. Lareau, Carlo Brugnara, Isabel Fulcher, Caroline Barau, Stéphane Moutereau, Anoosha Habibi, Bouchra Badaoui, Jugurtha Berkenou, Pablo Bartolucci et al. · 2019 · American Journal of Hematology
54. High fetal hemoglobin level is associated with increased risk of cerebral vasculopathy in children with sickle cell disease in Mayotte
    Abdourahim Chamouine, Thoueiba Saandi, M. Muszlak, Juliette Larmaraud, Laurent Lambrecht, Jean Pierre Poisson, Julien Balicchi, Serge Pissard, Narcisse Elenga · 2020 · BMC Pediatrics
55. Sickle cell anemia induces changes in peripheral lymphocytes E-NTPDase/E-ADA activities and cytokines secretion in patients under treatment
    Lívia G. Castilhos, Pedro H. Doleski, Tatiana M.D. Bertoldo, Daniela F. Passos, Cláudia de Mello Bertoncheli, João Felipe Peres Rezer, Josiane Bizzi Schlemmer Braun, Daniela Bitencourt Rosa Leal · 2015 · Biomedicine & Pharmacotherapy
56. Muscle dysfunction is associated with poorer health-related quality of life in adults with sickle cell anaemia
    C.E.A. Gonçalves, Priscila Oliveira Silva, Maurício Soares, Priscila dos Santos Bunn, Carla Martins de Araujo Lima, Agnaldo José Lopes · 2018 · Journal of Back and Musculoskeletal Rehabilitation
57. Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations
    Rayra Pereira Santiago, Camylla V. B. Figueiredo, Luciana Magalhães Fiuza, Sètondji Cocou Modeste Alexandre Yahouédéhou, Rodrigo Mota de Oliveira, Milena Magalhães Aleluia, Suéllen Pinheiro Carvalho, Cleverson Alves Fonseca, Valma Maria Lopes Nascimento, Larissa Rocha et al. · 2020 · Mediators of Inflammation
58. THE EFFECT OF ALPHA THALASSEMIA, HBF and HBC ON HAEMATOLOGICAL PARAMETERS OF SICKLE CELL DISEASE PATIENTS IN IBADAN, NIGERIA.
    FASOLA ATINUKE · 2022 · Mediterranean Journal of Hematology and Infectious Diseases
59. Modulation of Heme-Induced Inflammation Using MicroRNA-Loaded Liposomes: Implications for Hemolytic Disorders Such as Malaria and Sickle Cell Disease
    Alaijah Bashi, Cecilia Elorm Lekpor, Joshua L. Hood, Winston E. Thompson, Jonathan K. Stiles, Adel Driss · 2023 · International Journal of Molecular Sciences
60. Alpha thalassemia, but not βS-globin haplotypes, influence sickle cell anemia clinical outcome in a large, single-center Brazilian cohort
    Betânia Lucena Domingues Hatzlhofer, Diego A. Pereira‐Martins, Igor F. Domingos, Gabriela da Silva Arcanjo, Isabel Weinhäuser, Diego Arruda Falcão, Isabela Cristina Cordeiro Farias, Jéssica Vitória Gadelha de Freitas Batista, Luana Priscilla Laranjeira Prado, Jéssica Maria Oliveira et al. · 2021 · Annals of Hematology
61. Association of alpha‐thalassemia and Glucose‐6‐Phosphate Dehydrogenase deficiency with transcranial Doppler ultrasonography in Nigerian children with sickle cell anemia
    Oyesola Oyewole Ojewunmi, Titilope Adenike Adeyemo, Ajoke Idayat Oyetunji, Yewande Benn, Mfoniso Godwin Ekpo, Bamidele Abiodun Iwalokun · 2021 · Journal of Clinical Laboratory Analysis
62. Common polymorphic OTC variants can act as genetic modifiers of enzymatic activity
    Mónica Lopes‐Marques, Ana Rita Pacheco, Maria João Peixoto, Ana R. Cardoso, Catarina Serrano, António Amorim, Maria João Prata, D.N. Cooper, Luı́sa Azevedo · 2021 · Human Mutation
63. Co-Inheritance of α-Thalassemia Gene Mutation in Patients with Sickle Cell Disease
    ZA Ali Al-Barazanchi, SS Abdulateef, Meàad Kadhum Hassan · 2021 · Nigerian Journal of Clinical Practice
64. Interventions for chronic kidney disease in people with sickle cell disease
    Noemi B. A. Roy, Abigail Carpenter, Isabella Dale-Harris, Carolyn J. Doree, Lise J Estcourt · 2023 · Cochrane Database of Systematic Reviews
65. Effect of Assorted Globin Haplotypes and α-Thalassemia on the Clinical Heterogeneity of Hb S-β-Thalassemia
    Preetinanda Manaswini Dash, Praveen Kishore Sahu, Siris Patel, Ranjeet Singh Mashon, Kiran R. Kharat, Malay B. Mukherjee · 2018 · Hemoglobin
66. Interventions for preventing silent cerebral infarcts in people with sickle cell disease
    Lise J Estcourt, Patricia M Fortin, Sally Hopewell, Marialena Trivella, Carolyn J. Doree, Miguel Raul Abboud · 2016 · Cochrane Database of Systematic Reviews
67. Predictors of Intensive Care Admission Among Adult Patients with Sickle Cell Disease in Eastern Province of Saudi Arabia
    Mortadah Alsalman, Zaenb Husain Alsalman, Hussain Abduljaleel Alkhalifa, Aman Alfaraj, Ali Hussain Alkhalifah, Qasem Ahmed Almulihi · 2023 · Journal of Blood Medicine
68. Genetic contribution and functional impairment of inflammasome in sickle cell disease
    Valéria de Freitas Dutra, Vinícius Nunes Cordeiro Leal, Fernanda Pereira Fernandes, Cláudia Regina Lustosa Souza, Maria Stella Figueiredo, Alessandra Pontillo · 2021 · Cytokine
69. Hb F Levels in Indian Sickle Cell Patients and Association with the HBB Locus Variant rs10128556 (C>T), and the HBG XmnI (Arab-Indian) Variant
    Aparna Amarendra Bhanushali, Himani Kumari, Pradeep Kumar Patra, Bibhu Ranjan Das · 2017 · Hemoglobin
70. KLF1: when less is more
    Deepa G. Manwani, James J. Bieker · 2014 · Blood
71. Thyroid hemodynamic alterations in Egyptian patients with sickle cell disease: relation to disease severity, total body iron and thyroid function.
    Mohsen Saleh Elalfy, Nayera H. K. Elsherif, Hossam Moussa Sakr, Mahmoud Nemr Mohamed El Ashkar · 2019 · Expert Review of Hematology
72. Transcranial Doppler Velocities among Sickle Cell Disease Patients in Steady State
    Khaled Salama, Rasha Rady, Rania Hamdy Hashem, Mona El-Ghamrawy · 2020 · Hemoglobin
73. Phyto-Medicine in Gene(s) Targeting Future Direction for Sickle Cell Disease Management
    Lukman Adewale Alli, Michael P. Okoh · 2016 · Hereditary Genetics
74. Sickle cell anemia – Nitric oxide related genetic modifiers of hematological and biochemical parameters
    Laura Aguiar, Andreia Matos, Ângela Gil, Conceição Afonso, Salomé de Almeida, Lígia Braga, João Lavinha, Paula Kjöllerström, Paula Faustino, Manuel Bicho et al. · 2016 · Clinical Hemorheology and Microcirculation
75. Sickle Cell Nephropathy: Current Understanding of the Presentation, Diagnostic and Therapeutic Challenges
    Baba P. D. Inusa, Mariachiara Lodi, Giovanni Palazzi, Kenneth I. Ataga · 2018 · InTech eBooks
76. Impact of genetic polymorphisms in key enzymes of homocysteine metabolism on the pathophysiology of sickle cell anemia
    Danilo Grünig Humberto da Silva, Edis Belini-Junior, Lidiane S. Torres, Jéssika Viviani Okumura, Willian Marcel Barberino, Renan Garcia de Oliveira, Vanessa Urbinatti Teixeira, Clarisse Lopes de Castro Lobo, Eduardo Alves de Almeida, Cláudia R. Bonini-Domingos · 2017 · Free Radical Biology and Medicine
77. Longitudinal neurocognitive effects of nonmyeloablative hematopoietic stem cell transplant among older adolescents and adults with sickle cell disease: A description and comparison with sibling donors
    Emily J. Carlson, Nour Al Ghriwati, Pam Wolters, Mary Anne Tamula, John F. Tisdale, Courtney D. Fitzhugh, Matt Hsieh, Staci C. Martin · 2023 · Neuropsychological Rehabilitation
78. Burden of sickle cell anemia in Africa: A systematic review and meta-analysis
    Bwambale Jonani, Emmanuel Charles Kasule, Bwire Roman Herman, Joel Fredrick Arturo, Mwesigwa Calvin Mugambwa, Ssebulime Stephen, John Bosco Mundaka, Richard Kwizera, Gerald Mboowa, Felix Bongomin · 2025 · PLoS ONE
79. Impact of Genetic Variations on Thromboembolic Risk in Saudis with Sickle Cell Disease
    Mohammad A. Alshabeeb, Deemah Alwadaani, Farjah H. Al Qahtani, Salah Abohelaika, Mohsen Alzahrani, Abdullah Al Zayed, Hussain H. Al Saeed, Hala Alajmi, Barrak Alsomaie, Mamoon Rashid et al. · 2023 · Genes
80. Neurological abnormalities among pediatric patients with sickle cell disease in Saudi Arabia: a single-center retrospective study
    Ziad T. Basuni, Dania A. Monagel, Areej Taha, Nehal Ahmed, Amany A.E. Ahmed · 2024 · Frontiers in Pediatrics
81. The Application of Clinical and Molecular Diagnostic Techniques to Identify a Rare Haemoglobin Variant
    Michela Salvatici, C. Caslini, Simona Alesci, Grazia Arosio, Giuliana Meroni, Ferruccio Ceriotti, Massimiliano Ammirabile, Lorenzo Drago · 2024 · International Journal of Molecular Sciences
82. Poverty and severity of childhood sickle cell disease
    Oladele Simeon Olatunya · 2020 · British Journal of Haematology
83. Laboratory predictors of sickle cell disease severity: a cross-sectional study
    Mortadah Alsalman · 2024 · Journal of Medicine and Life
84. Influence of β-Globin Haplotypes on Oxidative Stress, Antioxidant Capacity and Inflammation in Sickle Cell Patients of Chhattisgarh
    Sanjana Bhagat, Amar Singh Thakur · 2018 · Indian Journal of Clinical Biochemistry
85. Exploring putative genetic determinants of inter-individual phenotypic heterogeneity in sickle cell disease: A cross-sectional Jamaican cohort-based study
    Kwesi Marshall, Sharon Howell, Asha V. Badaloo, Marvin Ellsworth Reid, Norma McFarlane‐Anderson, Colin A. McKenzie · 2018 · Blood Cells Molecules and Diseases
86. TGFBR3 Polymorphisms (rs1805110 and rs7526590) Are Associated with Laboratory Biomarkers and Clinical Manifestations in Sickle Cell Anemia
    Rayra Pereira Santiago, Camylla Vilas Boas Figueiredo, Luciana Magalhães Fiuza, Sètondji Cocou Modeste Alexandre Yahouédéhou, Rodrigo Mota de Oliveira, Milena Magalhães Aleluia, Suéllen Pinheiro Carvalho, Cleverson Alves Fonseca, Valma Maria Lopes Nascimento, Larissa Carneiro Rocha et al. · 2020 · Disease Markers
87. The Natural History of Hb S/Hereditary Persistence of Fetal Hemoglobin in 13 Children from the State of Minas Gerais, Brazil
    André Rolim Belisário, Rahyssa Rodrigues Sales, Célia M. Silva, Cibele Velloso‐Rodrigues, Marcos Borato Viana · 2016 · Hemoglobin
88. Haemolysis in sickle cell anaemia: effects of polymorphisms in α‐globin gene regulatory elements
    Jacqueline N. Milton, Elmutaz Shaikho Elhaj Mohammed, Martin H. Steinberg · 2019 · British Journal of Haematology
89. Disrupted homeostasis in sickle cells: Expanding the comprehension of metabolism adaptation and related therapeutic strategies
    Victoria Simões Bernardo, Flaviene Felix Torres, Ana Clara Albertin Zucão, Nayara Alves Chaves, Ilana Luize Rocha Santana, Danilo Grünig Humberto da Silva · 2025 · Tissue and Cell
90. Erythrocyte Alloimmunization and Transfusion Strategies in Sickle Cell Disease: A Single-Center Analysis
    Abdulaziz Yusuf, Abrar Ahmad, Hesham Abdelaziz El-Beshbishy, Heba Gong, Chahed Chahdah, Tahani Bakhsh · 2025 · Journal of Blood Medicine
91. Hydroxyurea for secondary stroke prevention in children with sickle cell anaemia: a systematic review of clinical evidence and outcomes
    Nicholas Aderinto, Gbolahan Deji Olatunji, Emmanuel Kokori, Abdulbasit Opeyemi Muili · 2024 · Annals of Medicine and Surgery
92. Human genetic variations conferring resistance to malaria
    X Zhang, Jie Wu, Yunxing Peng, Lan Luo, Lu Zhang, Xi Xiao Huang, Guoying Chen, Yirong Li, Haoan Yi · 2025 · Journal of Translational Medicine
93. Primary polymerization prevention
    Martin H. Steinberg · 2019 · Blood
94. Association of HMIP1 C-893A polymorphism and disease severity in patients with sickle cell anemia
    Diego A. Pereira‐Martins, Igor F. Domingos, Edis Belini-Junior, Juan Luiz Coelho‐Silva, Isabel Weinhäuser, Aderson Silva Araujo, Clarisse Lopes de Castro Lobo, Cláudia R. Bonini-Domingos, Marcos Bezerra, Antonio Roberto Lucena-Araujo · 2020 · Hematology Transfusion and Cell Therapy
95. Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients
    Hareram Pandey, Kanwaljeet Singh, Ravi Ranjan, Jasmita Dass, Seema Tyagi, Tulika Seth, Renu Saxena, Manoranjan Mahapatra · 2023 · Journal of Laboratory Physicians
96. Pathophysiology of Sickle Cell Disease
    Patricia Ann Shi, Narla Mohandas · 2014 · Elsevier eBooks
97. Perspective: A novel prognostic for sickle cell disease
    Brian Mozeleski, Abdullah M. Al‐Rubaish, Amein K. Al‐Ali, José R. Romero · 2018 · Saudi Journal of Medicine and Medical Sciences
98. Chronic Hydroxyurea Therapy in Children with Sickle Cell Anemia: Mechanisms of Action, Systemic Effects, and Long-Term Safety
    Federica Fogliazza, Martina Berzieri, Giulia Carbone, Davide Ciriaco, Susanna Esposito · 2025 · Journal of Clinical Medicine
99. Acute kidney injury is more common in hospitalised children with sickle cell anaemia in Africa
    Adetokunbo Olayinka Joacquim, Adeseye Michael Akinsete, Christopher Imokhuede Esezobor · 2023 · Acta Paediatrica
100. Prevalence of Thalassaemia Mutations in Sickle Cell Disease Population of Madhya Pradesh, Central India
     Monika Singh, G Sudhakar, Rajasubramaniam Shanmugam · 2016 · International Journal of Current Microbiology and Applied Sciences